A recent study showcased the effectiveness of Cytovale's IntelliSep® sepsis test in improving early sepsis risk stratification and enhancing documentation accuracy. This advancement led to a notable 29% increase in SEP-1 compliance rates. The study was presented at the American College of Emergency Medicine conference, held in San Francisco and Salt Lake City on September 7th, 2025.